Molecular confirmation that fibrocartilaginous dysplasia is a variant of fibrous dysplasia.

AIMS

Fibrocartilaginous dysplasia (FCD) is a subvariant of fibrous dysplasia (FD). This study aims to retrospectively elucidate the clinicopathological and separate genetic features of the cartilaginous and fibro-osseous components of FCD.

METHODS

In total, 24 patients (14 men and 10 women) with FCD were included in our cohort. The diagnosis was confirmed morphologically and immunohistochemically, and genetic features were determined via Sanger sequencing.

RESULTS

Five patients were polyostotic, and 19 were monostotic, predominantly concerning the femur. Radiography revealed a well-demarcated ground glass appearance with ring-like or scattered calcification. Histologically, the lesions were characterised by proliferative fibroblasts, immature woven bone and highly differentiated hyaline cartilage. The fibro-osseous components exhibited positive immunoreaction with SATB2 and a low Ki-67 proliferation index. The fibro-osseous and cartilaginous components shared mutations at codon 201 in exon 8 of the guanine nucleotide-binding protein/a-subunit ( gene, specifically CGT>CAT (p.R201H) in four patients and the wild-type isocitrate dehydrogenase ( gene. Telomerase reverse transcriptase ( promoter mutations (C288T and C229G) occurred in both fibro-osseous and cartilaginous components in two patients.

CONCLUSIONS

FCD encompasses areas of conventional FD with additional cartilage. Importantly, the presence or absence of mutations in the gene and/or the promoter is common between the fibro-osseous and cartilaginous components of the disease. These results further confirmed FCD as a variant of FD.